Drug-Associated Vanishing Bile Duct Syndrome: Screening for Potential Pharmaceutical Triggers Using the WHO Pharmacovigilance Database. [PDF]
Soares JP, Kremer AE, Bonzon J.
europepmc +1 more source
Pregnancy adverse events with immune checkpoint inhibitors in monotherapy and combination therapy in cancer: a disproportionality analysis. [PDF]
Alghamdi EA +12 more
europepmc +1 more source
Ecopharmacovigilance and pharmacovigilance: an analysis of environment-related reporting in VigiBase. [PDF]
Mitchell J +5 more
europepmc +1 more source
Sirolimus Therapy and Dyslipidemia in Neonates and Infants: A Retrospective Cohort and Pharmacovigilance Analysis. [PDF]
Taniguchi A +9 more
europepmc +1 more source
Patterns of pregabalin misuse: Need for intervention. [PDF]
Sarvepalli T +3 more
europepmc +1 more source
Integrated Evidence from VigiBase and Clinical Trials: A Comprehensive Pharmacovigilance Analysis of Seven Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs). [PDF]
Li J, Liang J, Zhang W, He J, Ye X.
europepmc +1 more source
The Role of Pharmacovigilance Database in Identifying Antibiotic Resistance and Inappropriate Use: An Analysis of VigiBase Reports From Lower-Middle-Income Countries. [PDF]
Saleh H +3 more
europepmc +1 more source
Consciousness Disturbances Reported With Clindamycin Versus Cefazolin in Surgical Patients: A Global Pharmacovigilance Analysis Using VigiBase. [PDF]
Nishida K +8 more
europepmc +1 more source
Dysesthesia associated with GLP-1 agonist therapies: data-mining analysis and literature review. [PDF]
Laroche ML, Géniaux H, Jardou M.
europepmc +1 more source
The Burden of Adverse Drug Reactions in Africa in the Context of Pharmacogenetics-Based Clinical Guidelines. [PDF]
Scholefield J +5 more
europepmc +1 more source

